Gynecologic pathology

Answers for even the most difficult cases

In gynecologic pathology, we see a wide variety of cases, from ovarian tumors and endometrial lesions to gestational disease problems. Our section members have trained at various institutions and in various subspecialty areas adding valuable insights to the range of cases we see.

4,500+

cases seen each year

7

subspecialized pathologists

Requesting a pathology consult

Our best practices enable expeditious, evidence-based results. Click here to learn more about Mayo Clinic Laboratories consultation request process.

Pathology in Focus

Gary Keeney, M.D., gives an overview of the gynecologic pathology service and the benefits of testing through Mayo Clinic Laboratories.

Expertise

Debra Bell, M.D.

Gynecologic pathologist and professor of Laboratory Medicine and Pathology

Amy Clayton, M.D.

Division Chair of Anatomic Pathology, gynecologic pathologist, and professor of Laboratory Medicine and Pathology

Michael Henry, M.D.

Gynecologic pathologist and professor of Laboratory Medicine and Pathology

Yajue Huang, M.D., Ph.D.

Gynecologic pathologist and associate professor of Laboratory Medicine and Pathology

Gary Keeney, M.D.

Gynecologic pathologist and professor of Laboratory Medicine and Pathology

Michael Roh, M.D., Ph.D.

Gynecologic pathologist and associate professor of Laboratory Medicine and Pathology

J. Kenneth Schoolmeester, M.D.

Head of Gynecologic Pathology Section and assistant professor of Laboratory Medicine and Pathology

Testing

PATHC | Pathology Consultation

Gynecologic sarcomas and tumors

ESTUF | Endometrial Stromal Tumors (EST), 7p15 (JAZF1), 6p21.32 (PHF1), 17p13.3 (YWHAE) Rearrangement, FISH, Tissue

SARCP | Sarcoma Targeted Gene Fusion/Rearrangement Panel, Next-Generation Sequencing, Tumor

Detection of high and/or low risk HPV by DNA in situ hybridization

HPVLR | Human Papillomavirus (HPV) Low Risk, DNA In Situ Hybridization

HPVHR | Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization

Detection of high risk HPV E6/E7 transcripts by RNA in situ hybridization

HPVE6 | Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization

Genomic copy number and structural analysis for products of conception

CMAMT | Chromosomal Microarray, Autopsy/Products of Conception/Stillbirth, Tissue

Learn more about how to order these evaluations at your institution.